Overview

Assess Efficacy in Subjects With Traumatic Spinal Cord Injury

Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
Assess efficacy of Vardenafil in patients with traumatic spinal cord injury
Phase:
Phase 4
Details
Lead Sponsor:
Bayer
Treatments:
Vardenafil Dihydrochloride